Background
==========

Inflammation plays key roles in invasion, angiogenesis and metastasis. Given the multifaceted roles of tumor-necrosis-factor-alpha (TNF-alpha) in these processes, its effects on the stromal fibroblasts that constitute the desmoplastic stroma in colorectal metastases are of interest.

Methods
=======

Primary cultures of cancer-associated stromal fibroblasts (CAFs) were generated from human tissues harvested during hepatic resection. TNF-alpha expression in tissue was examined by immunohistochemistry. Activation of nuclear-factor-kappaB (NF-kappaB) activity was measured by gel mobility shift assay. The effect of TNF-alpha on migratory capacity and gene expression of CAFs was tested in presence/absence of parthenolide, an herbal inhibitor of NF-kappaB. Gene expression in tissues and cell cultures was examined by Northern blot analysis. Protein measurements in the cell culture supernatant were performed with cytometric capture beads.

Results
=======

The colorectal metastases display immunoreactivity for TNF-alpha in tumor cells and leukocyte cells, whereas stromal fibroblasts are negative. To investigate transcriptional effects of TNF-alpha on CAFs, we analysed the expression of potential inflammatory target genes that are involved in tumor progression. CAFs that were exposed for 24 hours to TNF-alpha (10 ng/ml) showed a dramatic increased expression of interleukin-6 (IL-6), monocyte-chemotactic protein-1 (MCP-1) and intercellular cell adhesion molecule-1 (ICAM-1). Increasing concentrations of parthenolide (1, 5, 10 microM) dose-dependently inhibited the activation of NF-kappaB by TNF-alpha exposure for 30 min, as well as the TNF-alpha effect on IL-6 and MCP-1 mRNA and protein expression. Exposure of CAFs with TNF-alpha significantly increased the chemotaxis of HT29 colon carcinoma cells towards these cells in a coculture migration chamber system. This migratory effect activated by paracrine TNF-alpha was inhibited by co-incubation with parthenolide.

Conclusion
==========

CAFs are an important target for inflammatory signaling mediated by TNF-alpha/NF-kappaB in the context of tumor-stroma interaction and may play an important role in metastasis progression. Our results suggest that the inhibition of NF-kappaB activation may be an interesting strategy in antitumor therapy targeting hepatic colorectal carcinoma metastatis.
